473 related articles for article (PubMed ID: 34820787)
1. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management.
Rudrabhatla PK; Reghukumar A; Thomas SV
Acta Neurol Belg; 2022 Apr; 122(2):273-280. PubMed ID: 34820787
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 associated mucormycosis - An emerging threat.
Chao CM; Lai CC; Yu WL
J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
[TBL] [Abstract][Full Text] [Related]
3. Mucormycosis in the COVID-19 Environment: A Multifaceted Complication.
Sharma R; Kumar P; Rauf A; Chaudhary A; Prajapati PK; Emran TB; Gonçalves Lima CM; Conte-Junior CA
Front Cell Infect Microbiol; 2022; 12():937481. PubMed ID: 35923801
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR;
Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
7. Mucormycosis, past and present: a comprehensive review.
Gupta I; Baranwal P; Singh G; Gupta V
Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
9. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review.
Shah NN; Khan Z; Ahad H; Elderdery AY; Alomary MN; Atwah B; Alhindi Z; Alsugoor MH; Elkhalifa AME; Nabi S; Bashir SM; Yaqub T; Rather GA; Ansari MA
J Infect Public Health; 2022 Nov; 15(11):1299-1314. PubMed ID: 36279686
[TBL] [Abstract][Full Text] [Related]
10. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.
Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S
Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877
[TBL] [Abstract][Full Text] [Related]
11. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
[TBL] [Abstract][Full Text] [Related]
12. [COVID-19 associated mucormycosis. A case in Argentina].
Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
[TBL] [Abstract][Full Text] [Related]
14. Satellite Epidemic of Covid-19 Associated Mucormycosis in India: A Multi-Site Observational Study.
Satija A; Anand T; Mukherjee A; Velamuri PS; Singh KJ; Das M; Josten K; Keche AY; Nagarkar NM; Gupta P; Himanshu D; Mistry SN; Patel JD; Rao P; Rohatgi S; Ghosh S; Hazra A; Kindo AJ; Annamalai R; Rudramurthy SM; Singh MP; Shameem M; Fatima N; Khambholja JR; Parikh S; Madkaikar M; Pradhan VD; Bhargava A; Mehata R; Arora RD; Tigga R; Banerjee G; Sonkar V; Malhotra HS; Kumar N; Patil R; Raut CG; Bhattacharyya K; Arthur P; Somu L; Srikanth P; Shah PB; Panda NK; Sharma D; Hasan W; Ahmed A; Bathla M; Solanki S; Doshi H; Kanani Y; Patel N; Shah Z; Tembhurne AK; Rajguru C; Sankhe LR; Chavan SS; Yadav RM; Panda S
Mycopathologia; 2023 Oct; 188(5):745-753. PubMed ID: 37490256
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.
Huang SF; Ying-Jung Wu A; Shin-Jung Lee S; Huang YS; Lee CY; Yang TL; Wang HW; Chen HJ; Chen YC; Ho TS; Kuo CF; Lin YT;
J Microbiol Immunol Infect; 2023 Jun; 56(3):442-454. PubMed ID: 36586744
[TBL] [Abstract][Full Text] [Related]
16. Mucor in a Viral Land: A Tale of Two Pathogens.
Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.
Rao VUS; Arakeri G; Madikeri G; Shah A; Oeppen RS; Brennan PA
Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1095-1098. PubMed ID: 34507870
[TBL] [Abstract][Full Text] [Related]
18. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.
Rudramurthy SM; Hoenigl M; Meis JF; Cornely OA; Muthu V; Gangneux JP; Perfect J; Chakrabarti A;
Mycoses; 2021 Sep; 64(9):1028-1037. PubMed ID: 34133816
[TBL] [Abstract][Full Text] [Related]
19. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
[TBL] [Abstract][Full Text] [Related]
20. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
